FDA Approves Suzatrigine: A Revolutionary 25-Year Pain Reliever That Provides Non-Opioid Relief
FDA approves Suzatrigin FDA approves Suzatrigin : The U.S. Food and Drug Administration (FDA) has made a significant breakthrough by approving Suzatrigin, the first new class of pain reliever in 25 years. This innovative drug, sold under the brand name Jernvax, promises to revolutionize pain management by providing an effective non-opioid alternative for acute pain …